MOORSIDE PHARMA DEVELOPMENTS LIMITED
BRADFORD

Hellopages » West Yorkshire » Bradford » BD2 3AA

Company number 07930921
Status Active
Incorporation Date 1 February 2012
Company Type Private Limited Company
Address 372 DUDLEY HILL ROAD, BRADFORD, WEST YORKSHIRE, BD2 3AA
Home Country United Kingdom
Nature of Business 47730 - Dispensing chemist in specialised stores, 86900 - Other human health activities
Phone, email, etc

Since the company registration sixteen events have happened. The last three records are Confirmation statement made on 1 February 2017 with updates; Total exemption small company accounts made up to 29 February 2016; Annual return made up to 1 February 2016 with full list of shareholders Statement of capital on 2016-02-27 GBP 620 . The most likely internet sites of MOORSIDE PHARMA DEVELOPMENTS LIMITED are www.moorsidepharmadevelopments.co.uk, and www.moorside-pharma-developments.co.uk. The predicted number of employees is 1 to 10. The company’s age is thirteen years and ten months. Moorside Pharma Developments Limited is a Private Limited Company. The company registration number is 07930921. Moorside Pharma Developments Limited has been working since 01 February 2012. The present status of the company is Active. The registered address of Moorside Pharma Developments Limited is 372 Dudley Hill Road Bradford West Yorkshire Bd2 3aa. . BOYLE, Andrew John is a Director of the company. CLEASBY, Steven John, Dr is a Director of the company. COLE, Jonathan David is a Director of the company. DIXON, Jonathan Alan, Dr is a Director of the company. HODGSON, Philip is a Director of the company. KHODADI, Mahmoud is a Director of the company. SULLIVAN, John Marcus, Dr is a Director of the company. Director BOOTH, Nicola Ann has been resigned. The company operates in "Dispensing chemist in specialised stores".


Current Directors

Director
BOYLE, Andrew John
Appointed Date: 01 February 2012
68 years old

Director
CLEASBY, Steven John, Dr
Appointed Date: 01 February 2012
54 years old

Director
COLE, Jonathan David
Appointed Date: 01 February 2012
54 years old

Director
DIXON, Jonathan Alan, Dr
Appointed Date: 01 February 2012
55 years old

Director
HODGSON, Philip
Appointed Date: 01 February 2012
68 years old

Director
KHODADI, Mahmoud
Appointed Date: 01 February 2012
38 years old

Director
SULLIVAN, John Marcus, Dr
Appointed Date: 01 February 2012
62 years old

Resigned Directors

Director
BOOTH, Nicola Ann
Resigned: 01 November 2014
Appointed Date: 01 November 2012
50 years old

Persons With Significant Control

Rycroft Partnership Llp
Notified on: 6 April 2016
Nature of control: Ownership of shares – More than 25% but not more than 50%

MOORSIDE PHARMA DEVELOPMENTS LIMITED Events

21 Feb 2017
Confirmation statement made on 1 February 2017 with updates
30 Nov 2016
Total exemption small company accounts made up to 29 February 2016
27 Feb 2016
Annual return made up to 1 February 2016 with full list of shareholders
Statement of capital on 2016-02-27
  • GBP 620

30 Nov 2015
Total exemption small company accounts made up to 28 February 2015
07 Mar 2015
Annual return made up to 1 February 2015 with full list of shareholders
Statement of capital on 2015-03-07
  • GBP 640

...
... and 6 more events
04 Feb 2013
Annual return made up to 1 February 2013 with full list of shareholders
04 Feb 2013
Appointment of Mrs Nicola Ann Booth as a director
13 Dec 2012
Registered office address changed from St. Andrew's House St. Andrew's Street Leeds West Yorkshire LS3 1LF United Kingdom on 13 December 2012
04 May 2012
Particulars of a mortgage or charge / charge no: 1
01 Feb 2012
Incorporation
  • MODEL ARTICLES ‐ Model articles adopted (Amended Provisions)

MOORSIDE PHARMA DEVELOPMENTS LIMITED Charges

27 October 2014
Charge code 0793 0921 0002
Delivered: 1 November 2014
Status: Outstanding
Persons entitled: Lloyds Bank PLC
Description: Contains fixed charge…
1 May 2012
Debenture
Delivered: 4 May 2012
Status: Outstanding
Persons entitled: Hsbc Bank PLC
Description: Fixed and floating charge over the undertaking and all…